2m 2m 2m 2m 2m 2m 2m
MATINAS BIO (MTNB)
NYSE
$0.65+$0.004 (+0.60%)
Price as of Jun 23, 2026 7:53 PM EDT- $4.0MMarket Cap
- -28.30%1-Year Change
- BiotechnologyIndustry
MATINAS BIO (MTNB)
$0.65+$0.004 (+0.60%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 0 -100.00% | 1.1M -65.62% | 3.2M +9,464.10% | |
Cost of Revenue | N/A N/A | 24.6M -1.08% | 24.9M -10.50% | 27.8M +12.15% | |
Gross Profit | 0 +100.00% | -24.6M +3.48% | -23.8M -3.35% | -24.6M -0.59% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -85,000 -99.26% | -11.4M -21.09% | -14.5M -13.13% | -16.7M +14.36% | |
Depreciation and Amortization Expense | 32,000 -91.23% | 365,000 -5.19% | 385,000 +14.24% | 337,000 +37.89% | |
Total Operating Expenses | 7.0M -71.70% | 24.6M -1.08% | 24.9M -10.50% | 27.8M +12.15% | |
Operating Profit | -7.0M -71.70% | -24.6M +3.48% | -23.8M -3.35% | -24.6M -0.59% | |
Interest Income | N/A N/A | N/A N/A | 484,000 -86.14% | 3.5M +162.78% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 484,000 -86.14% | 3.5M +162.78% | |
Total Nonoperating Income and Expense | -261,000 -199.62% | 262,000 -22.94% | 340,000 +233.33% | 102,000 -16.99% | |
Income before Taxes | -10.3M -57.48% | -24.3M +2.38% | -23.8M +13.19% | -21.0M -11.33% | |
Income Taxes | 7,000 +108.75% | -80,000 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.0M -54.38% | -24.0M +4.74% | -22.9M +9.26% | -21.0M -9.82% | |
Net Income from Continuing Operations Applicable to Common | -11.0M -54.94% | -24.3M +6.05% | -22.9M +9.26% | -21.0M -11.33% | |
Basic EPS and Net Income | -2.00 -59.84% | -4.98 +4,427.27% | -0.11 +10.00% | -0.10 -9.09% | |
Diluted EPS and Net Income | -2.00 -59.84% | -4.98 +4,427.27% | -0.11 +10.00% | -0.10 -9.09% | |
Basic Weighted Average Shares | 5.5M +12.50% | 4.9M -97.76% | 217.3M +0.21% | 216.8M +3.16% | |
Diluted Weighted Average Shares | 5.5M +12.50% | 4.9M -97.76% | 217.3M +0.21% | 216.8M +3.16% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.0M -45.10% | 7.3M +52.16% | 4.8M -29.91% | 6.8M -67.52% | |
Short-Term Investments | N/A N/A | N/A N/A | 9.0M -59.11% | 21.9M -23.29% | |
Cash and Cash Equivalents and Short-Term Investments | 4.0M -45.10% | 7.3M -47.05% | 13.8M -52.17% | 28.8M -42.04% | |
Total Current Assets | 4.1M -49.22% | 8.0M -48.37% | 15.5M -54.99% | 34.5M -32.28% | |
Accumulated Depreciation | 28,000 -98.64% | 2.1M +21.53% | 1.7M +23.81% | 1.4M +32.02% | |
Property and Plant and Equipment and Net | 138,000 -70.51% | 468,000 -75.66% | 1.9M -8.03% | 2.1M +35.98% | |
Total Long-Term Assets | 3.1M -32.13% | 4.6M -51.72% | 9.6M -7.06% | 10.3M -0.44% | |
Total Assets | 7.2M -42.98% | 12.6M -49.65% | 25.1M -43.99% | 44.8M -26.92% | |
Income Taxes Payable | 257,000 0.00% | 257,000 -24.63% | 341,000 0.00% | 341,000 -0.08% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.5M -45.12% | 2.7M +1.68% | 2.6M -38.82% | 4.3M -1.44% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 915,000 -61.64% | 2.4M -26.30% | 3.2M -16.94% | 3.9M -13.12% | |
Total Liabilities | 2.4M -52.92% | 5.1M -13.78% | 5.9M -28.40% | 8.2M -7.37% | |
Retained Earnings | -210.8M +5.49% | -199.8M +13.81% | -175.6M +15.03% | -152.6M +15.95% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 19.2M -47.47% | 36.6M -30.21% | |
Total Shares Outstanding | 6.4M +25.93% | 5.1M -97.66% | 217.3M 0.00% | 217.3M +0.46% | |
Cash Flow | |||||
Cash from Operating Activities | -7.0M -55.86% | -15.9M +3.97% | -15.3M -20.24% | -19.2M +25.83% | |
Capital Expenditures | N/A N/A | N/A N/A | 218,000 -75.56% | 892,000 +242.58% | |
Cash from Investing Activities | 335,000 -96.36% | 9.2M -30.46% | 13.2M +171.52% | 4.9M -70.92% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.4M -63.04% | 9.2M +131,157.14% | -7,000 -108.86% | 79,000 -98.87% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | -2,168.43% +181.13% | -771.33% -98.96% | |
Operating Margin | N/A N/A | N/A N/A | -2,168.43% +181.13% | -771.33% -98.96% | |
Return on Assets | -110.46% -13.24% | -127.33% +94.04% | -65.62% +65.86% | -39.56% +12.40% | |
Return on Equity | N/A N/A | N/A N/A | -82.11% +74.27% | -47.12% +17.59% | |
Revenue Growth | N/A N/A | -100.00% +52.39% | -65.62% -100.69% | 9,464.10% +12,087.83% | |
Current Ratio | 2.79 -7.46% | 3.01 -49.22% | 5.93 -26.42% | 8.06 -31.29% | |
Cash Ratio | 2.73 +0.04% | 2.73 +49.65% | 1.83 +14.56% | 1.59 -67.05% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow